For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211103:nRSC1347Ra&default-theme=true
RNS Number : 1347R Agronomics Limited 03 November 2021
3 November 2021
Agronomics Limited (https://agronomics.im/)
("Agronomics" or the "Company")
Announces Launch of New Website
Agronomics, the leading listed company focused on the field of cellular
agriculture, is pleased to announce the launch of its new website, found at
www.agronomics.im (http://www.agronomics.im) .
This new website aligns with Agronomics focus on identifying cellular
agriculture opportunities, inclusive of cultivated meat, biomass fermentation
and precision fermentation. The Company to date has participated in
early-stage funding rounds of BlueNalu, Meatable, VitroLabs, Solar Foods,
Formo, Mosa Meat, LIVEKINDLY, Tropic Biosciences, California Cultured,
SuperMeat, CellX, GALY, Bond Pet Foods, Shiok Meats, New Age Meats and
Rebellyous Foods. All of which can be found under portfolio highlights on the
new website.
About Agronomics (https://agronomics.im/)
Agronomics is a leading listed alternative proteins company with a focus on
cellular agriculture and cultivated meat. The Company has established a
portfolio of 16 companies at the Seed to Series B stage in this rapidly
advancing sector. It seeks to secure minority stakes in companies owning
technologies with defensible intellectual property that offer new ways of
producing food and materials with a focus on products historically derived
from animals. These technologies are driving a major disruption in
agriculture, offering solutions to improve sustainability, as well as
addressing human health, animal welfare and environmental damage. This
disruption will decouple supply chains from the environment and animals, as
well as being fundamental to feeding the world's expanding population. A full
list of Agronomics' portfolio companies is available at https://agronomics.im/
(https://agronomics.im/) .
About Cellular Agriculture
Over the coming decades, the source of the world's food supply traditionally
derived from animals is going to change dramatically. We have already
witnessed the first wave of this shift with consumer adoption of plant-based
alternative proteins but today, we are on the cusp of an even bigger wave of
change, which is being facilitated by advances in cellular agriculture - the
production of proteins and materials directly from cells and single-celled
organisms.
AT Kearney, a global consultancy firm, projects that cultivated meat's market
share will reach 35% by 2040. This combined with the Good Food Institute's
estimate that a US $1.8 trillion investment will be required in order to
produce just 10% of the world's protein using this technology, means that we
are on the cusp of a multi-decade flow of capital.
Scientists believe that if we maintain current animal protein consumption
patterns and continue using animals to produce meat and other proteins from
animals, that we cannot meet the Paris Agreement's goals of limiting warming
to 1.5℃.
Funding in the field of cellular agriculture is accelerating, however still
less than US$ 1 billion has been invested worldwide since the industry's
inception in 2016. The Good Food Institute estimates Additional financings are
anticipated as the capital requirements of these companies grows to build out
and scale up manufacturing facilities. Currently it is estimated that there
are 60 companies globally within the sector.
For further information please contact:
Agronomics Beaumont Cenkos Peterhouse Capital TB Cardew
Limited Cornish Limited Securities Plc Limited
The Company Nomad Joint Broker Joint Broker
Public Relations
Richard Reed Roland Cornish Giles Balleny Lucy Williams Ed Orlebar
Denham Eke James Biddle Michael Johnson Charles Goodfellow Joe McGregor
+44 (0) 1624 639396 +44 (0) 207 628 3396 +44 (0) 207 397 8900 +44 (0) 207 469 0936 +44 (0) 20 7930 0777
info@agronomics.im +44 (0) 7738 724 630
agronomics@tbcardew.com
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRABTBBTMTMMTLB